Parikh, Aparna <br/><br/>
Prolonged Response to HER2-Directed Therapy in a Patient With HER2-Amplified, Rapidly Progressive Metastatic Colorectal Cancer.  [electronic resource] 

 -  Journal of the National Comprehensive Cancer Network : JNCCN  01 2017 
 - 3-8 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article 
<br/><br/><label>ISSN: </label>1540-1413 
<br/><br/><label>Standard No.: </label>10.6004/jnccn.2017.0002  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Ado-Trastuzumab Emtansine<br/>Antibodies, Monoclonal, Humanized--administration & dosage<br/>Antineoplastic Agents--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Biopsy<br/>Camptothecin--administration & dosage<br/>Chemoradiotherapy, Adjuvant<br/>Colorectal Neoplasms--diagnosis<br/>DNA Mutational Analysis--methods<br/>Disease Progression<br/>Drug Resistance, Neoplasm<br/>Fluorouracil--administration & dosage<br/>Gene Amplification<br/>High-Throughput Nucleotide Sequencing<br/>Humans<br/>Laparoscopy<br/>Leucovorin--administration & dosage<br/>Liver Neoplasms--genetics<br/>Male<br/>Maytansine--administration & dosage<br/>Middle Aged<br/>Molecular Targeted Therapy--methods<br/>Off-Label Use<br/>Palliative Care--methods<br/>Proto-Oncogene Proteins c-myc--genetics<br/>Receptor, ErbB-2--genetics<br/>Tomography, X-Ray Computed<br/>Trastuzumab<br/>Tumor Suppressor Protein p53--genetics<br/>Ultrasonography